Sign up Australia
Proactive Investors - Run By Investors For Investors

PressureBioSciences upbeat after fund-raising tops expectations

The company has increased the capacity of the offering to a maximum of US$6.25 million.
PressureBioSciences upbeat after fund-raising tops expectations
Having cleared its variable convertible debt, the company can invest the funds in ramping up sales promotion

Pressure BioSciences (OTCMKTS:PBIO), the pressure cycling technology company, has exceeded its US$5mln private investment in public equity (PIPE) goal.

The company announced the passing of the milestone following the receipt of $255,000 in gross proceeds from the fifth closing of its $5 million private placement. This closing increased the total amount raised in the offering to $5,010,000, which is actually more than the offering was supposed to raise, so the company increased the capacity of the PIPE to a maximum of US$6.25mln.

"The vast majority of funds raised to date have been used to eliminate 100% of the company's variable rate (floorless) convertible debt. With our significantly improved balance sheet now in hand, all funds received from the over-subscription amount will be used to support operating activities,” said Richard Schumacher, president and chief executive officer of Pressure BioSciences.

“With ramping sales, new and further improved product offerings, the planned expansion of our sales and marketing capabilities, and the expected announcement of a world-class, formidable, multi-national co-marketing partner, we believe we will achieve operational and financial growth levels in 2016 that will surpass any previous year, including our record shattering 2015 performance," Schumacher added.

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

1511808112_surgeon.jpg
January 09 2018
The device can now be sold to aid in heart treatment throughout the European Union
picture of addict
November 16 2017
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
couple looking at pregnancy test
November 13 2017
The proceeds from the fundraiser will be used to expand in the People's Republic and will invested in product development

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use